Formycon AG's total inventories for the quarter that ended in Dec. 2025 was €2.05 Mil. Formycon AG's average total inventories from the quarter that ended in Jun. 2025 to the quarter that ended in Dec. 2025 was €1.61 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Formycon AG's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was €-14.49.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Formycon AG's Days Inventory for the
six
months ended in Dec. 2025 was 15.95.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Formycon AG's Inventory Turnover for the quarter that ended in Dec. 2025 was 11.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Formycon AG's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.05.
Formycon AG (HAM:FYB) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Formycon AG's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Formycon AG's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Formycon AG Total Inventories Related Terms
Formycon AG Total Inventories Historical Data
* Premium members only.
The historical data trend for Formycon AG's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Formycon AG (HAM:FYB) has a Total Inventories of €2.05 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Formycon AG and its competitors.
Is Formycon AG's Total Inventories too high?
Formycon AG's current Total Inventories is €2.05 Mil. Overall, Formycon AG has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Formycon AG's Total Inventories compare to VRTX and REGN?
Formycon AG's Total Inventories of €2.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Formycon AG and its competitors. Formycon AG's current Total Inventories is €2.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formycon AG stock overvalued right now?
Based on GuruFocus' analysis, Formycon AG (HAM:FYB) is currently considered Possible Value Trap. The stock's GF Value™ is €35.48, compared to a current price of €18.86 — trading 46.8% below its estimated fair value. The current Total Inventories is €2.05 Mil. Formycon AG's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Formycon AG (HAM:FYB), the current Total Inventories is €2.05 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Formycon AG (HAM:FYB) Overvalued in 2026?
Based on GuruFocus' analysis, Formycon AG stock appears to be undervalued.
The current stock price of €18.86 is trading 46.8% below its estimated GF Value™ of €35.48.
GuruFocus considers Formycon AG to be Possible Value Trap.
Key valuation signals for HAM:FYB:
Total Inventories: €2.05 Mil
GF Value™: €35.48 vs. price of €18.86 (46.8% below fair value)
No single metric tells the full story. See the HAM:FYB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Formycon AG is an independent developer of high-quality biosimilars, which are follow-on products to biopharmaceutical drugs. The Company focuses on expanding and further developing its scalable biosimilar platform, which includes approved and pipeline products across ophthalmology, immunology, and immuno-oncology. Its key products include FYB201 (ranibizumab), FYB202 (ustekinumab), FYB203 (aflibercept), FYB206 (pembrolizumab), and FYB208 (dupilumab), along with additional biosimilar candidates in various stages of development. The Company generates maximum revenue from Switzerland.
65GF Score
Get the complete analysis for HAM:FYB
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:FYB has been successfully added to your 
